Genespire
About:
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Website: http://www.genespire.com/
Top Investors: Sofinnova Partners, CDP Venture Capital, Indaco Venture Partners, XGEN Venture
Description:
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
Total Funding Amount:
62.6M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Milan, Lombardia, Italy
Founded Date:
2020-03-01
Contact Email:
info(AT)genespire.com
Founders:
Alessio Cantore, Luigi Naldini
Number of Employees:
1-10
Last Funding Date:
2024-09-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai